Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks. [electronic resource]
Producer: 20130607Description: 184-188.e2 p. digitalISSN:- 1534-4436
- Adolescent
- Adult
- Aged
- Anaphylaxis -- drug therapy
- Angioedemas, Hereditary -- drug therapy
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Disease Progression
- Epinephrine -- therapeutic use
- Female
- Humans
- Injections, Subcutaneous
- Larynx -- drug effects
- Male
- Middle Aged
- Peptides -- administration & dosage
- Risk
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.